233 related articles for article (PubMed ID: 24859216)
1. Understanding intellectual disability through RASopathies.
San Martín A; Pagani MR
J Physiol Paris; 2014; 108(4-6):232-9. PubMed ID: 24859216
[TBL] [Abstract][Full Text] [Related]
2. Mosaic RASopathies.
Hafner C; Groesser L
Cell Cycle; 2013 Jan; 12(1):43-50. PubMed ID: 23255105
[TBL] [Abstract][Full Text] [Related]
3. Severe Intellectual Disability and Enhanced Gamma-Aminobutyric Acidergic Synaptogenesis in a Novel Model of Rare RASopathies.
Papale A; d'Isa R; Menna E; Cerovic M; Solari N; Hardingham N; Cambiaghi M; Cursi M; Barbacid M; Leocani L; Fasano S; Matteoli M; Brambilla R
Biol Psychiatry; 2017 Feb; 81(3):179-192. PubMed ID: 27587266
[TBL] [Abstract][Full Text] [Related]
4. The sixth international RASopathies symposium: Precision medicine-From promise to practice.
Gripp KW; Schill L; Schoyer L; Stronach B; Bennett AM; Blaser S; Brown A; Burdine R; Burkitt-Wright E; Castel P; Darilek S; Dias A; Dyer T; Ellis M; Erickson G; Gelb BD; Green T; Gross A; Ho A; Holder JL; Inoue SI; Jelin AC; Kennedy A; Klein R; Kontaridis MI; Magoulas P; McConnell DB; McCormick F; Neel BG; Prada CE; Rauen KA; Roberts A; Rodriguez-Viciana P; Rosen N; Rumbaugh G; Sablina A; Solman M; Tartaglia M; Thomas A; Timmer WC; Venkatachalam K; Walsh KS; Wolters PL; Yi JS; Zenker M; Ratner N
Am J Med Genet A; 2020 Mar; 182(3):597-606. PubMed ID: 31825160
[TBL] [Abstract][Full Text] [Related]
5. De novo mutations in the GTP/GDP-binding region of RALA, a RAS-like small GTPase, cause intellectual disability and developmental delay.
Hiatt SM; Neu MB; Ramaker RC; Hardigan AA; Prokop JW; Hancarova M; Prchalova D; Havlovicova M; Prchal J; Stranecky V; Yim DKC; Powis Z; Keren B; Nava C; Mignot C; Rio M; Revah-Politi A; Hemati P; Stong N; Iglesias AD; Suchy SF; Willaert R; Wentzensen IM; Wheeler PG; Brick L; Kozenko M; Hurst ACE; Wheless JW; Lacassie Y; Myers RM; Barsh GS; Sedlacek Z; Cooper GM
PLoS Genet; 2018 Nov; 14(11):e1007671. PubMed ID: 30500825
[TBL] [Abstract][Full Text] [Related]
6. Fruit flies and intellectual disability.
Bolduc FV; Tully T
Fly (Austin); 2009; 3(1):91-104. PubMed ID: 19182539
[TBL] [Abstract][Full Text] [Related]
7. The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation.
Tidyman WE; Rauen KA
Curr Opin Genet Dev; 2009 Jun; 19(3):230-6. PubMed ID: 19467855
[TBL] [Abstract][Full Text] [Related]
8. NRAS associated RASopathy and embryonal rhabdomyosarcoma.
Garren B; Stephan M; Hogue JS
Am J Med Genet A; 2020 Jan; 182(1):195-200. PubMed ID: 31697451
[TBL] [Abstract][Full Text] [Related]
9. Rescue of Learning and Memory Deficits in the Human Nonsyndromic Intellectual Disability Cereblon Knock-Out Mouse Model by Targeting the AMP-Activated Protein Kinase-mTORC1 Translational Pathway.
Bavley CC; Rice RC; Fischer DK; Fakira AK; Byrne M; Kosovsky M; Rizzo BK; Del Prete D; Alaedini A; Morón JA; Higgins JJ; D'Adamio L; Rajadhyaksha AM
J Neurosci; 2018 Mar; 38(11):2780-2795. PubMed ID: 29459374
[TBL] [Abstract][Full Text] [Related]
10. The RASopathies as an example of RAS/MAPK pathway disturbances - clinical presentation and molecular pathogenesis of selected syndromes.
Bezniakow N; Gos M; Obersztyn E
Dev Period Med; 2014; 18(3):285-96. PubMed ID: 25182392
[TBL] [Abstract][Full Text] [Related]
11. Genetics of childhood disorders: LII. Learning and memory, part 5: human cognitive disorders and the ras/ERK/CREB pathway.
Sweatt JD; Weeber EJ
J Am Acad Child Adolesc Psychiatry; 2003 Jul; 42(7):873-6. PubMed ID: 12819448
[No Abstract] [Full Text] [Related]
12. Proceedings of the fifth international RASopathies symposium: When development and cancer intersect.
Rauen KA; Schoyer L; Schill L; Stronach B; Albeck J; Andresen BS; Cavé H; Ellis M; Fruchtman SM; Gelb BD; Gibson CC; Gripp K; Hefner E; Huang WYC; Itkin M; Kerr B; Linardic CM; McMahon M; Oberlander B; Perlstein E; Ratner N; Rogers L; Schenck A; Shankar S; Shvartsman S; Stevenson DA; Stites EC; Stork PJS; Sun C; Therrien M; Ullian EM; Widemann BC; Yeh E; Zampino G; Zenker M; Timmer W; McCormick F
Am J Med Genet A; 2018 Dec; 176(12):2924-2929. PubMed ID: 30302932
[TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular analysis of RASopathies in a group of Turkish patients.
Şimşek-Kiper PÖ; Alanay Y; Gülhan B; Lissewski C; Türkyilmaz D; Alehan D; Cetin M; Utine GE; Zenker M; Boduroğlu K
Clin Genet; 2013 Feb; 83(2):181-6. PubMed ID: 22420426
[TBL] [Abstract][Full Text] [Related]
14. RASopathies: unraveling mechanisms with animal models.
Jindal GA; Goyal Y; Burdine RD; Rauen KA; Shvartsman SY
Dis Model Mech; 2015 Aug; 8(8):769-82. PubMed ID: 26203125
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of RAS activation due to a homozygous ezrin variant in patients with profound intellectual disability.
Riecken LB; Tawamie H; Dornblut C; Buchert R; Ismayel A; Schulz A; Schumacher J; Sticht H; Pohl KJ; Cui Y; Reis A; Morrison H; Abou Jamra R
Hum Mutat; 2015 Feb; 36(2):270-8. PubMed ID: 25504542
[TBL] [Abstract][Full Text] [Related]
16. RASopathy Gene Mutations in Melanoma.
Halaban R; Krauthammer M
J Invest Dermatol; 2016 Sep; 136(9):1755-1759. PubMed ID: 27236105
[TBL] [Abstract][Full Text] [Related]
17. [Rasopathies: developmental disorders that predispose to cancer and skin manifestations].
Hernández-Martín A; Torrelo A
Actas Dermosifiliogr; 2011; 102(6):402-16. PubMed ID: 21536246
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of Börjeson-Forssman-Lehmann syndrome: Insights from PHF6 function.
Jahani-Asl A; Cheng C; Zhang C; Bonni A
Neurobiol Dis; 2016 Dec; 96():227-235. PubMed ID: 27633282
[TBL] [Abstract][Full Text] [Related]
19. The kinase suppressor of Ras (KSR) modulates growth factor and Ras signaling by uncoupling Elk-1 phosphorylation from MAP kinase activation.
Sugimoto T; Stewart S; Han M; Guan KL
EMBO J; 1998 Mar; 17(6):1717-27. PubMed ID: 9501093
[TBL] [Abstract][Full Text] [Related]
20. Molecular neurobiology of human cognition.
Weeber EJ; Sweatt JD
Neuron; 2002 Mar; 33(6):845-8. PubMed ID: 11906692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
